ee ee BROOKHAVEN NATIONAL LABORATORY bene wae™ é . a Ihe. ASSOCIATED UNIVERSITIES, INC. 40.827 Medical Department Upton, NewYork 11973 (516) 345-3577 March 9, 1978 Xr. Arthur C. Upton, Director National Cancer Institute Bethesda, Maryland 20014 Dear Art, First, I want to thank you for helping with arrangements with Dr. Heberman to screen the Marshallese sera from the forthcoming survey for feto and ACG antibodies. show up on any of them Should anything suspicious we will naturally follow up with other studies. Second, you will remember we met with Vic Bond and Gene Cronkite concerning malignancies that could be reasonably associated with radiation exposure with regard to compensation in the exposed Marshallese. We decided that, based on present data (mostly from the Japanese), we would consider the following: Leukemia, thyroid tumors, and cancers of the lung, breast and stomach and GI tract. Our decisions as to whom should be recommended for compensation is of course of great concern to the Marshallese and it is possible we may have to justify our decisions particularly if legal complications develop. Should you not agree at this time with our earlier conclusions I would appreciate hearing from you. With best regards. Sincerely, Robert A. Conard, M.D. RAC: gc cC: Dr. V.P. Bond Dr. E.P. Cronkite 90108943 .